Effectiveness of Pfizer–BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021
MMWR Morb. Mortal. Wkly. Rep. 2021 Oct 22;70(42)1483-1488, SM Olson, MM Newhams, NB Halasa, AM Price, JA Boom, LC Sahni, K Irby, TC Walker, SP Schwartz, PS Pannaraj, AB Maddux, TT Bradford, RA Nofziger, BJ Boutselis, ML Cullimore, EH Mack, JE Schuster, SJ Gertz, NZ Cvijanovich, M Kong, MA Cameron, MA Staat, ER Levy, BM Chatani, K Chiotos, LD Zambrano, AP Campbell, MM Patel, AG RandolphFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.